Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Inventory (2016 - 2025)

Arcadia Biosciences' Inventory history spans 12 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Inventory rose 34.07% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 34.07%, while the annual FY2025 figure was $1.2 million, 34.07% up from the prior year.
  • Inventory reached $1.2 million in Q4 2025 per RKDA's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $5.4 million in Q3 2021 to a low of $835000.0 in Q3 2024.
  • Average Inventory over 5 years is $2.4 million, with a median of $2.5 million recorded in 2022.
  • Peak YoY movement for Inventory: skyrocketed 200.75% in 2021, then plummeted 69.09% in 2024.
  • A 5-year view of Inventory shows it stood at $4.4 million in 2021, then crashed by 47.64% to $2.3 million in 2022, then plummeted by 63.94% to $837000.0 in 2023, then rose by 8.0% to $904000.0 in 2024, then soared by 34.07% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Inventory are $1.2 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025).